Source: Annual Congress 2010 - Tuberculosis and HIV coinfection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. Arghir, C. Ciobotaru, M. Man, M. Trenchea, S. Rugina (Constantza, Cluj Napoca, Constanta, Romania). Site of active tuberculosis disease predicts survival in HIV-associated tuberculosis. Eur Respir J 2010; 36: Suppl. 54, 3865

Member's Comments

No comment yet.

Related content which might interest you: Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017 Year: 2018 Latent tuberculosis infection as a cause of tuberculosis disease Source: Eur Respir J 2003; 22: Suppl. 45, 157s Year: 2003 Knowledge of tuberculosis patients about tuberculosis disease Source: Eur Respir J 2006; 28: Suppl. 50, 19s Year: 2006 Crohn‘s disease or extrapulmonary tuberculosis? Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 Profiles of tuberculosis disease activation among contacts of patients with tuberculosis Source: Eur Respir J, 54 (4) 1900353; 10.1183/13993003.00353-2019 Year: 2019 The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands Source: Eur Respir J 2016; 48: 1420-1428 Year: 2016 Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 The definition of tuberculosis infection based on the spectrum of tuberculosis disease Source: Breathe, 17 (3) 210079; 10.1183/20734735.0079-2021 Year: 2021 Risk of disease and latent infection among contacts of pulmonary and pleural tuberculosis in santarem (Portugal) Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis Source: Eur Respir J 2016; 48: 1751-1763 Year: 2016 Who is at risk for active tuberculosis? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 Timing of relapse of tuberculosis in people with co-infection (HIV/TB) Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003 The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 Performance and post-treatment conversion of latent tuberculosis test (QUANTIFERON) in immunocompromised patients with neoplasmatic disease Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Progression to tuberculosis disease increases with multiple exposures Source: Eur Respir J 2016; 48: 1682-1689 Year: 2016 Treatment failure in tuberculosis Source: Eur Respir J 2007; 29: 561-564 Year: 2007